Data Standards

The appropriate collection and use of data is central to oncology research, clinical treatment, and coverage and reimbursement decisions. However, to accelerate research and development and improve the quality of care delivery, it is vital for organizations to not only understand how to handle, collect, store, and appropriately disseminate data but also to translate it into actionable information that can help transform healthcare delivery.


To develop a pilot for cross-institution and industry agreement on standardization, our standards working group has specifically focused on the development of and agreement to a standard set of must-measure elements for immuno-oncology assays.


David B. Agus, M.D.
Professor of Medicine and Engineering
Keck School of Medicine and Viterbi School of Engineering
Founding Director
Lawrence J. Ellison Institute for Transformative Medicine of USC
USC Westside Cancer Center
University of Southern California

Jeff Allen, Ph.D.
President and CEO
Friends of Cancer Research (Friends)

Steven D. Averbuch, M.D.
Private Consultant

Ann D. Barker, Ph.D.
Director, Transformative Healthcare Knowledge Networks
Co-Director, Complex Adaptive Systems Initiative
Professor, School of Life Sciences
Arizona State University

Shrujal Baxi, M.D., MPH
Medical Director
Flatiron Health

Kenneth D. Cole, Ph.D.
Group Leader
Bioassay Methods Biosystems and Biomaterials Division
National Institute of Standards and Technology (NIST)
US Department of Commerce

Carolyn C. Compton, MD. Ph.D.
Professor of Life Sciences
School of Life Sciences, Arizona State University
Adjunct Professor of Pathology
Johns Hopkins Medical Institute, Baltimore, MD
Professor of Pathology
University of Arizona, Tucson, AZ

Hua-Jun He, Ph.D.
Bioassay Methods Group
Biosystems and Biomaterials Division
National Institute of Standards and Technology (NIST)
US Department of Commerce

Samir N. Khleif, M.D.
The Loop Immuno-Oncology Research Laborator
Lombardi Cancer Center, Georgetown University
Evercare Global Cancer Centers Director, Global Cancer Research and Impact Institute

Jerry H. Lee, Ph.D.
Associate Professor of Clinical Medicine | Keck School of Medicine
Associate Professor of Chemical Engineering & Material Sciences | Viterbi School of Engineering
Chief Science and Innovation Officer | Lawrence J. Ellison Institute for Transformative Medicine
University of Southern California

Michael Pellini
Managing Partner
Section 32

Michael F. Press, M.D. Ph.D.
Professor of Pathology
Harold E. Lee Chair in Breast Cancer Research
Breast Cancer Analysis Lab

Eric H. Rubin, M.D.
SVP and Therapeutic Area Head, Early Stage Oncology Clinical Development

Greg C. Simon, J.D.
Biden Cancer Initiative

David Spetzler, Ph.D., MS, MBA
President and Chief Scientific Officer
Caris Life Sciences


Video Module: Patient data: who owns it, and for what purpose